HDA President and CEO Chester “Chip” Davis, Jr., released a statement regarding the U.S. Food and Drug Administration’s (FDA) granting of an Emergency Use Authorization (EUA) for the Johnson & Johnson (Janssen Biotech) COVID-19 vaccine candidate.
February marks Allied Against Opioid Abuse’s (AAOA) third year of bringing together healthcare stakeholders to increase awareness about prescription opioid safety.
The Healthcare Distribution Alliance (HDA) was named one of the 100 “Best Places to Work in Virginia” by Virginia Business magazine and Best Companies Group. This is the ninth year that HDA has received this distinction.
Following the Biden administration’s announcement of an increase in the supply of available vaccines for millions of Americans, Chester “Chip” Davis, Jr., President and CEO of the Healthcare Distribution Alliance (HDA), issued a statement.
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement in response to recent commentary related to the COVID-19 vaccination effort.
